5-146120383-G-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The ENST00000394434.7(LARS1):c.3313C>T(p.Arg1105Ter) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000093 in 1,612,694 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000068 ( 0 hom. )
Consequence
LARS1
ENST00000394434.7 stop_gained
ENST00000394434.7 stop_gained
Scores
5
1
1
Clinical Significance
Conservation
PhyloP100: 4.65
Genes affected
LARS1 (HGNC:6512): (leucyl-tRNA synthetase 1) This gene encodes a cytosolic leucine-tRNA synthetase, a member of the class I aminoacyl-tRNA synthetase family. The encoded enzyme catalyzes the ATP-dependent ligation of L-leucine to tRNA(Leu). It is found in the cytoplasm as part of a multisynthetase complex and interacts with the arginine tRNA synthetase through its C-terminal domain. A mutation in this gene was found in affected individuals with infantile liver failure syndrome 1. Alternatively spliced transcript variants of this gene have been observed. [provided by RefSeq, Dec 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0617 CDS is truncated, and there are 1 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 5-146120383-G-A is Pathogenic according to our data. Variant chr5-146120383-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 214577.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LARS1 | NM_020117.11 | c.3313C>T | p.Arg1105Ter | stop_gained | 31/32 | ENST00000394434.7 | NP_064502.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LARS1 | ENST00000394434.7 | c.3313C>T | p.Arg1105Ter | stop_gained | 31/32 | 1 | NM_020117.11 | ENSP00000377954 | P4 | |
ENST00000514002.1 | n.410G>A | non_coding_transcript_exon_variant | 3/3 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151974Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
5
AN:
151974
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250994Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135648
GnomAD3 exomes
AF:
AC:
5
AN:
250994
Hom.:
AF XY:
AC XY:
3
AN XY:
135648
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1460720Hom.: 0 Cov.: 30 AF XY: 0.00000688 AC XY: 5AN XY: 726628
GnomAD4 exome
AF:
AC:
10
AN:
1460720
Hom.:
Cov.:
30
AF XY:
AC XY:
5
AN XY:
726628
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151974Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74236
GnomAD4 genome
AF:
AC:
5
AN:
151974
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74236
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
2
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden | Nov 03, 2021 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2018 | - - |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Nov 04, 2022 | Variant summary: LARS c.3313C>T (p.Arg1105X) results in a premature termination codon, predicted to cause a truncation of the encoded protein. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 2e-05 in 250994 control chromosomes (gnomAD). c.3313C>T has been reported in the literature as a homozygous genotype in two siblings affected with Liver Failure Acute Infantile, Type 1 (e.g. Lenz_2020). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact of the variant on protein function in fibroblasts derived from a homozygous patient (e.g. Lenz_2020). The variant resulted in a truncated protein product but did not appear to undergo nonsense mediated decay. The protein showed reduced enzymatic activity, approximately 70% of normal, which was further reduced at higher temperatures to approximately 45% of normal, likely as a result of reduced protein stability, as indicated by a reduced expression at higher temperatures evaluated by western blotting. Three submitters have provided clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as either pathogenic (n=2) or likely pathogenic (n=1). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Infantile liver failure syndrome 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Aug 03, 2021 | This variant was identified as homozygous. - |
LARS1-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego | - | This nonsense variant found in exon 31 of 32 is predicted to result in protein truncation. This variant has been previously reported as a homozygous change in two related individuals with features of infantile liver failure syndrome 1 (ILFS1), however both were noted to lack the episodic liver dysfunction that is typical of the disorder (PMID: 32699352). Experimental studies have shown that the presence of the c.3313C>T (p.Arg1105Ter) variant leads to reduced LARS1 enzyme activity, and that the variant likely causes truncation of the LARS1 protein (PMID: 32699352). The c.3313C>T (p.Arg1105Ter) variant is present in the heterozygous state in the gnomAD population database at a frequency of 0.002479% (7/282358) and is absent in the homozygous state. Based on the available evidence, the c.3313C>T (p.Arg1105Ter) variant is classified as Likely Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
MutationTaster
Benign
D;D;D;D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at